UC Davis Alzheimer's Disease Research Center
加州大学戴维斯分校阿尔茨海默病研究中心
基本信息
- 批准号:10666428
- 负责人:
- 金额:$ 318.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-15 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAddressAffectAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease patientAlzheimer&aposs disease riskAreaAutopsyAwarenessBiological MarkersBloodCaregiver researchCaringCharacteristicsChargeClinicalCognitionCognitiveCommunitiesDataDatabase Management SystemsDatabasesDementiaDevelopmentDiagnosisDiseaseDisparityEarly DiagnosisEducational StatusElderlyEnvironmentFosteringFundingFutureGoalsHealth ProfessionalHeterogeneityImageImpaired cognitionIndividualInternationalInterventionInvestigationMeasuresMentorsMethodsMissionOutcomeParticipantPathologicPathologyPersonsPhenotypePopulationPopulation HeterogeneityPreventionPrevention strategyQualifyingResearchResearch ActivityResearch DesignResearch InfrastructureResearch MethodologyResearch PersonnelResearch SupportResourcesRisk FactorsRisk ReductionScanningScienceSecureServicesTechnologyTraining and EducationTranslational ResearchVascular DiseasesVisionWalkingaging brainbrain healthcareercaregivingcohortcollaborative environmentdementia riskdesigndisparity reductioneducation researcheffective therapyepidemiology studyethnic minority populationethnoracialhigh riskimaging biomarkerimprovedinnovationinsightinterdisciplinary collaborationinterestneuropathologynext generationnovelpreventracial minority populationrecruitrisk mitigationstemtherapy developmenttooltraining opportunity
项目摘要
PROJECT SUMMARY/ABSTRACT - Overall
The mission of the UC Davis Alzheimer’s Disease Research Center (UCD ADRC) is to promote a highly
innovative and enriched research environment focused on understanding the heterogeneity of brain aging
among diverse populations that will ultimately lead to effective therapies to prevent or mitigate dementia.
This approach stems from the premise that emphasizing diversity enhances discovery and contributes to
translational science as well as reducing disparities in brain health and care. To accomplish this
mission, the UCD ADRC has developed innovative methods and a unique study design to recruit and retain a
highly demographically diverse clinical and autopsy cohort. All UCD ADRC participants are longitudinally
followed and deeply phenotyped with extensive clinical, blood and imaging biomarker measures as well as
developing state-of-the-art quantitative neuropathology. The UCD ADRC succeeds at these efforts through a
robust research infrastructure, state-of-the-art database management and a highly collaborative environment
consisting of seven well integrated resource cores and one research education component (REC) designed to
facilitate new research efforts and interventions, dissemination of research findings, education and training as
well as encouraging researcher development. Our approach addresses several milestones set by the National
Alzheimer’s Project Act to effectively treat Alzheimer’s disease and associated disorders (ADRD) by 2025.
These include, but are not limited to: 1) M1.L., evaluating disparities among ethnic and racial minority
populations that are at higher risk for AD to mitigate risk and improve cognitive outcomes, 2) M2.H., fully
characterizing mixed pathologies and identifying unique risk factors,3) M5-7., accelerating the development of
treatments that would prevent, halt, or reverse the course of Alzheimer’s disease (AD), 4) M9., improving early
diagnosis through discovery of novel imaging and blood biomarkers, 5) M8., developing novel dementia
prevention strategies, and 6) M13.E.,supporting caregiving through funded caregiver research. The UCD
ADRC also directly supports multiple epidemiological studies of diverse communities through use of research
methods and personnel to gain further insights into dementia risk reduction, early diagnosis, and the impact of
various neuropathologies on aging and dementia.
Our efforts reflect the evolving needs of an increasingly older and more diverse US population, which is
expected to rise to nearly 14 million by midcentury. Moreover, while AD continues to be the major pathological
cause of dementia, more recent studies—including one from the UCD ADRC—find that dementia pathology is
multifactorial and highly heterogeneous, due in part to the co-occurrence of AD and vascular disease, which
varies by ethnoracial characteristics, is emphasized as part of dementia prediction and which can be modified
by treatment even in later life. The UCD ADRC is uniquely qualified to support this research focus with a
considerable impact on future ADRD diagnosis and treatment.
项目摘要/摘要-总体
项目成果
期刊论文数量(27)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Cholesterol, Amyloid Beta, Fructose, and LPS Influence ROS and ATP Concentrations and the Phagocytic Capacity of HMC3 Human Microglia Cell Line.
- DOI:10.3390/ijms241210396
- 发表时间:2023-06-20
- 期刊:
- 影响因子:5.6
- 作者:
- 通讯作者:
Non-invasive quantification of 18F-florbetaben with total-body EXPLORER PET.
使用全身 EXPLORER PET 对 18F-florbetaben 进行无创定量。
- DOI:10.21203/rs.3.rs-3764930/v1
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Holy,EmilyN;Li,Elizabeth;Bhattarai,Anjan;Fletcher,Evan;Alfaro,EvelynR;Harvey,DanielleJ;Spencer,BenjaminA;Cherry,SimonR;DeCarli,CharlesS;Fan,AudreyP
- 通讯作者:Fan,AudreyP
Resources for Enhancing Alzheimer's Caregiver Health in Vietnam (REACH VN): study protocol for a cluster randomized controlled trial to test the efficacy of a family dementia caregiver intervention in Vietnam.
- DOI:10.1186/s13063-022-06228-6
- 发表时间:2022-05-09
- 期刊:
- 影响因子:2.5
- 作者:
- 通讯作者:
Interaction between Alzheimer's Disease and Cerebral Small Vessel Disease: A Review Focused on Neuroimaging Markers.
- DOI:10.3390/ijms231810490
- 发表时间:2022-09-10
- 期刊:
- 影响因子:5.6
- 作者:Kim, Si Eun;Kim, Hee Jin;Jang, Hyemin;Weiner, Michael W.;DeCarli, Charles;Na, Duk L.;Seo, Sang Won
- 通讯作者:Seo, Sang Won
Cardiovascular health and cognitive outcomes: Findings from a biracial population-based study in the United States.
心血管健康和认知结果:美国一项基于混血人口的研究的结果。
- DOI:10.1002/alz.13421
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Dhana,Anisa;DeCarli,CharlesS;Dhana,Klodian;Desai,Pankaja;Holland,ThomasM;Evans,DenisA;Rajan,KumarB
- 通讯作者:Rajan,KumarB
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Charles DeCarli其他文献
Charles DeCarli的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Charles DeCarli', 18)}}的其他基金
Do Atmospheric Ultrafine Particles Lodge in the Brain and Cause Cognitive Decline Leading to Alzheimer's Disease Related Dementias?
大气超细颗粒是否会滞留在大脑中并导致认知能力下降,从而导致阿尔茨海默病相关的痴呆症?
- 批准号:
10591354 - 财政年份:2022
- 资助金额:
$ 318.85万 - 项目类别:
Study of Latinos-Investigation of Neurocognitive Aging-Alzheimer's disease
拉丁裔研究-神经认知衰老-阿尔茨海默病的调查
- 批准号:
10629449 - 财政年份:2022
- 资助金额:
$ 318.85万 - 项目类别:
Study of Latinos-Investigation of Neurocognitive Aging-Alzheimer's disease
拉丁裔研究-神经认知衰老-阿尔茨海默病的调查
- 批准号:
10370841 - 财政年份:2022
- 资助金额:
$ 318.85万 - 项目类别:
Early and life course socioeconomic adversity and dementia risk in Hispanics/Latinos
西班牙裔/拉丁裔的早期和生命历程社会经济逆境和痴呆风险
- 批准号:
10445900 - 财政年份:2022
- 资助金额:
$ 318.85万 - 项目类别:
Early and life course socioeconomic adversity and dementia risk in Hispanic/Latinos
西班牙裔/拉丁裔的早期和生命历程社会经济逆境和痴呆风险
- 批准号:
10831329 - 财政年份:2022
- 资助金额:
$ 318.85万 - 项目类别:
UC Davis Alzheimer's Disease Research Center
加州大学戴维斯分校阿尔茨海默病研究中心
- 批准号:
10461120 - 财政年份:2021
- 资助金额:
$ 318.85万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 318.85万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 318.85万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 318.85万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 318.85万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 318.85万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 318.85万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 318.85万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 318.85万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 318.85万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 318.85万 - 项目类别:
Research Grant














{{item.name}}会员




